Analysis and quantification of diagnostic serum markers and protein signaturs for Gaucher disease

Molecular and Cellular Proteomics

Volumn 6, Issue 5, 2007, Pages 755-766

  Vissers, Johannes P C ^a   Langridge, James I ^a   Aerts, Johannes M F G ^b  

^a WATERS CORPORATION   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOTRIOSIDASE; COMPLEMENT; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN;

ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME REPLACEMENT; GAUCHER DISEASE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; CLUSTER ANALYSIS; GAUCHER DISEASE; HEXOSAMINIDASES; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 34249657456     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M600303-MCP200     Document Type: Article

References (34)

1. Beutler E., and Grabowski, G. (1995) Gaucher disease, in The Metabolic Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds) pp. 2641-2670, McGraw-Hill Publishing Co., New York
2. Hollak, C. E. M., van Weely, S., van Oers, M. H. J., and Aerts, J. M. F. G. (1994) Marked elevation of plasma chitotriosidase activity; a novel hallmark of Gaucher disease. J. Clin. Investig. 93, 1288-1292
3. Boot, R. G., Renkema, G. H., Verhoek, M., Strijland, A., Bliek, J., de Meulemeester, T. M., Mannens, M. M., and Aerts, J. M. F. G. (1998) The human chitotriosidase gene. Nature of inherited enzyme deficiency. J. Biol. Chem. 273, 25680-25685
4. Barton, N. W., Furbish, F. S., Murray, G. J., Garfield, M., and Brady, R. O. (1990) Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc. Natl. Acad. Sci. U. S. A. 87, 1913-1916
5. Cox, T., Lachmann, R., Hollak, C. E., Aerts, J. M. F. G., van Weely, S., Hrebicek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., Gow, I., Elstein, D., and Zimran, A. (2000) Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT918) to decrease substrate biosynthesis. Lancet 355, 1481-1485
6. Aerts, J. M. F. G., Hollak, C. E. M., van Breemen, M., Maas, M., Groener, J. E., and Boot, R. G. (2005) Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases. Acta Paediatr. Suppl. 94, 43-46, 37-38
7. Boot, R. G., Verhoek, M., de Fost, M., Hollak, C. E. M., Maas, M., Bleijlevens, B., van Breemen, M. J., van Meurs, M., Boven, L. A., Leman, J. D., Moran, M. T., Cox, T. M., and Aerts, J. M. F. G. (2004) Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 103, 33-39
8. Rabilloud, T. (2002) Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2, 3-10
9. Corthals, G. L., Wasinger, V. C., Hochstrasser, D. F., and Sanchez, J. C. (2000) The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 21, 1104-1115
10. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biothechnol. 17, 994-999
11. Ross, R.L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplex protein quantification in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
12. Ong, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
13. Shevchenko, A., Chernushevich, I., Ens, W., Standing, K. G., Thomas, B., Wilm, M., and Mann, M. (1997) Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/ time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 11, 1015-1024
14. 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem. 73, 2836-2842
15. Lill, J. (2003) Proteomic tools for quantification by mass spectrometry. Mass Spectrom. Rev. 22, 182-194
16. Hamdan, M., and Righetti, P. G. (2002) Modern strategies of protein quantification in proteome analysis: advantages and limitations. Mass Spectrom. Rev. 21, 287-302
17. Ong, S.-E., and Mann, M. (2005) Mass spectrometry-based proteomics turn quantitative. Nat. Chem. Biol. 5, 252-262
18. Silva, J. C., Denny, R., Dorschel, C. A., Gorenstein, M., Kass, I. J., Li, G.-Z., McKenna, T., Nold, M. J., Richardson, K., Young, P., and Geromanos, S. J. (2005) Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 77, 2187-2200
19. Silva, J. C., Denny, R., Dorschel, C. A., Gorenstein, M. V., Li, G.-Z., Richardson, K., Wall, D., and Geromanos, S. J. (2006) Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol. Cell. Proteomics 5, 589-607
20. Hughes, M. A., Silva, J. C., Geromanos, S. J., and Townsed, C. A. (2006) Quantitative proteomic analysis of drug-induced changes in mycobacteria. J. Proteome Res. 5, 54-63
21. Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T. A., Hill, L. R., Norton, S., Kumar, P., Anderle, M., and Becker, C. (2003) Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 75, 4818-4826
22. Radulovic, D., Jelveh, S., Ryu, S., Hamilton, T. G., Foss, E., Mao, Y., and Emili, A. (2004) Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry. Mol. Cell. Proteomics 3, 984-997
23. Wiener, M. C., Sachs, J. R., Deyanova, E. G., and Yates, N. A. (2004) Differential mass spectrometry: a label-free LC-MS method for finding differences in complex peptide and protein mixtures. Anal. Chem. 76, 6085-6096
24. America, A. H. P., Cordewener, J. H. G., van Geffen, M. H. A., Lommen, A., Vissers, J. P. C., Bino, R. J., and Hall, R. D. (2006) Alignment and statistical difference analysis of complex peptide data sets generated by multidimensional LC-MS. Proteomics 6, 641-653
25. E. A virtue of parallel MS acquisition. Mol. Cell. Proteomics 5, 144-156
26. Yu, Y. Q., Gilar, M., Lee, P. J., Bouvier, E. S. P., and Gebler, J. C. (2003) Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. Anal. Chem. 75, 6023-6028
27. Bateman, R. H., Langridge, J. I., McKenna, T., and Richardson, K. Methods and Apparatus for Mass Spectrometry. U. S. Patent 2,385,918A, September 26, 2006
28. Bateman, R. H., Carruthers, R., Hoyes, J. B., Jones C., Langridge, J. I., Millar, A., and Vissers, J. P. C. (2002) A novel precursor ion discovery method on a hybrid quadrupole orthogonal acceleration time-of-flight mass spectrometer for studying protein phosphorylation. J. Am. Soc. Mass Spectrom. 13, 792-803
29. Fortier, M.-H., Bonneil, E., Goodley, P., and Thibault, P. (2005) Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs. Anal. Chem. 77, 1631-1640
30. Ghitun, M., Bonneil, E., Fortier, M.-H., Yin, H., Killeen, K., and Thibault, P. (2006) Integrated microfluidic devices with enhanced separation performance: application to phosphoproteome analyses of differentiated cell model systems. J. Sep. Sci. 29, 1539-1549
31. Aerts, J. M. F. G., Donker-Koopman, W. E., Koot, M., Barranger, J. A., Tager, J. M., and Schram, A. W. (1986) Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease. Clin. Chim. Acta 158, 155-164
32. Hollak, C. E. M., Levi, M., Barends, F., Aerts, J. M. F. G., and van Oers, H. J. (1997) Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br. J. Haematolog. 96, 470-476
33. Anderson, L. (2005) Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 563, 23-60
34. Janeway, C. A., Jr., Travers, P., Walport, M., Shlomchik, M. J. (2001) in Immunobiology, Part 1, an Introduction to Immunobiology and Innate Immunity, 5th Ed., pp. 1-92, Garland Publishing, New York